Do personal story and informational videos encourage older adults to get vaccinated?
Official title: Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults
Run by Johns Hopkins Bloomberg School of Public Health · NCT06890403 · Data updated 2026-11-12
This project will try informational videos, personal story videos, and a mix of both to see which best increases vaccination among U.S. adults aged 50 and older.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 6000 (estimated) |
| Sponsor | Johns Hopkins Bloomberg School of Public Health Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | September 16, 2025 |
| Main results expected | September 24, 2026 |
| Study ends | January 2027 |
| Registry record updated | February 13, 2026 |
| Trial ID | NCT06890403 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
U.S. adults aged 50 and older who can view and listen to videos on their device and complete brief surveys are ideal candidates for this project.
✕Probably not a fit
People who cannot or will not view videos on their device, who fail to complete required surveys, or who are already firmly unwilling to be vaccinated are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants aged 50 and older in the United States will be shown one of three video formats: an informational animation, a personal narrative, or a combination of both, and their subsequent vaccination behavior will be tracked. The intervention is delivered via participants' own devices and requires completion of pre- and post-viewing surveys. Recruitment and data collection are conducted in partnership with Ipsos, with Johns Hopkins Bloomberg School of Public Health as the lead sponsor and Merck collaborating. The trial compares the relative effectiveness of narrative versus informational messaging on vaccine uptake in an older adult population.
Why it matters
Potential benefit: If successful, the findings could identify simple, scalable video messaging that increases vaccination rates among older adults.
How similar studies have gone: Prior communication research shows mixed but promising results for personal narratives improving vaccine attitudes, though evidence on actual uptake among older adults is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * U.S. adults aged 50 and older Exclusion Criteria: * Participants who do not complete the survey * Participants who are unable or refuse to view and listen to videos on the participant's device
Where it's running
-
Ipsos
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Daniel Salmon, PhD — Johns Hopkins University
- Study coordinator: Michelle Goryn
- Email: mgoryn1@jh.edu
- Phone: 919-357-2484
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RSV vaccine safety and immune response in lung transplant patients vs. healthy adults
This study tests how well the RSV vaccine works and how safe it is in people who have had a lung transplant compared with healthy adults.
-
Sleep and Teens’ Immune Response to a Meningococcal Vaccine
This study checks if 11- to 12-year-olds’ sleep habits affect how well their vaccine for meningococcal disease works.
-
OptiMAx: testing SQ-LNS to boost vaccination in rural Chad and Niger
This study tests whether giving small-batch SQ-LNS to young children helps increase routine immunizations in rural Chad and Niger.
-
Using fingerprint-linked digital records and reminders to help children finish their malaria and routine vaccines
This project will test whether a biometric-linked digital vaccination system plus voice-message reminders can help children in Ghana complete their malaria and routine vaccines.
-
Which vaccine messages grab attention in rural New England
This online test uses short social-media vaccine messages delivered by either experts or influencers to see which ones better catch attention and influence attitudes among adults living in rural New England.
-
Neutralizing power of blood and nasal antibodies
This project will test how strong blood and nasal antibodies remain over time in adults getting COVID-19 or monkeypox vaccines or antibody treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.